Luye Pharma Group Ltd banner

Luye Pharma Group Ltd
HKEX:2186

Watchlist Manager
Luye Pharma Group Ltd Logo
Luye Pharma Group Ltd
HKEX:2186
Watchlist
Price: 2.99 HKD -1.32% Market Closed
Market Cap: HK$11.9B

Balance Sheet

Balance Sheet Decomposition
Luye Pharma Group Ltd

Balance Sheet
Luye Pharma Group Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
1
42
23
53
95
117
275
400
252
364
333
332
844
398
1 266
1 673
2 327
3 865
2 438
2 324
3 239
4 937
4 492
Cash
1
42
23
53
95
117
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
0
0
0
0
0
0
275
400
252
364
333
332
844
398
1 266
1 673
2 327
3 865
2 438
2 324
3 239
4 937
4 492
Short-Term Investments
53
90
47
43
48
1
0
0
0
0
10
1 845
2 363
2 350
2 575
3 190
2 863
1 541
3 072
3 221
2 867
1 566
3 004
Total Receivables
86
97
133
171
237
238
307
341
477
542
877
952
1 272
1 547
1 490
1 633
1 942
1 807
2 388
2 266
2 592
4 301
3 259
Accounts Receivables
71
90
123
149
183
168
212
247
310
337
391
633
620
953
912
1 139
1 211
950
1 515
1 432
1 978
2 384
3 259
Other Receivables
15
7
10
22
54
70
95
94
167
205
486
319
652
594
578
494
731
856
873
834
614
1 917
0
Inventory
16
28
29
34
42
56
58
73
105
143
235
251
286
453
420
586
617
612
746
773
828
912
957
Other Current Assets
7
5
22
35
43
34
66
81
97
39
197
145
307
536
544
1 594
1 773
2 145
1 752
2 203
1 177
1 592
3 522
Total Current Assets
162
262
254
335
465
446
707
895
930
1 089
1 652
3 526
5 071
5 282
6 296
8 675
9 522
9 970
10 397
10 786
10 703
13 308
15 233
PP&E Net
100
95
115
109
149
152
234
366
693
808
975
1 126
1 245
1 746
2 241
2 979
3 947
4 339
4 594
4 909
5 155
6 050
6 064
PP&E Gross
100
95
115
109
149
152
234
366
693
808
975
1 126
1 245
1 746
2 241
2 979
3 947
4 339
4 594
4 909
5 155
6 050
0
Accumulated Depreciation
32
42
52
65
96
111
124
145
170
197
233
290
348
593
735
889
1 121
1 386
1 647
1 984
2 333
2 672
0
Intangible Assets
10
9
9
48
225
200
367
341
406
174
136
146
126
856
829
4 445
4 685
4 770
5 442
5 985
6 318
6 585
6 783
Goodwill
0
0
6
44
166
166
188
188
359
347
347
347
347
996
1 037
1 041
1 038
1 057
985
1 003
1 042
1 012
1 075
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
9
0
0
0
Long-Term Investments
1
1
5
9
105
92
5
7
6
7
10
8
8
8
41
84
72
71
582
1 114
1 968
2 492
3 596
Other Long-Term Assets
0
6
5
293
8
10
24
25
60
253
267
977
255
317
317
315
144
415
573
444
304
164
74
Other Assets
0
0
6
44
166
166
188
188
359
347
347
347
347
996
1 037
1 041
1 038
1 057
985
1 003
1 042
1 012
1 075
Total Assets
274
N/A
373
+36%
393
+5%
839
+113%
1 120
+33%
1 067
-5%
1 524
+43%
1 822
+20%
2 454
+35%
2 678
+9%
3 387
+26%
6 131
+81%
7 053
+15%
9 206
+31%
10 760
+17%
17 539
+63%
19 408
+11%
20 631
+6%
22 582
+9%
24 250
+7%
25 491
+5%
29 612
+16%
32 825
+11%
Liabilities
Accounts Payable
12
12
10
14
11
13
14
23
37
50
56
59
83
116
87
201
239
326
323
418
427
504
1 153
Accrued Liabilities
27
17
18
63
51
28
75
69
138
108
142
193
93
197
250
379
340
210
430
686
747
626
0
Short-Term Debt
26
0
0
0
0
0
144
264
452
445
736
305
502
1 624
2 878
5 275
3 908
5 574
4 987
4 865
4 908
5 303
0
Current Portion of Long-Term Debt
62
49
11
29
137
66
27
0
2
0
0
0
0
0
0
94
235
228
523
2 117
628
2 467
6 694
Other Current Liabilities
0
0
2
3
5
32
61
103
262
281
369
331
367
438
439
2 254
980
896
1 066
1 401
1 428
1 869
2 088
Total Current Liabilities
128
78
41
108
204
139
321
459
891
884
1 303
888
1 045
2 375
3 655
8 203
5 703
7 234
7 330
9 487
8 138
10 769
9 936
Long-Term Debt
37
8
0
0
116
75
30
1
2
26
9
1
0
0
0
848
4 510
4 339
4 228
2 265
3 228
2 736
3 621
Deferred Income Tax
0
0
0
2
26
31
70
82
94
117
99
98
92
121
96
89
78
74
58
56
47
36
0
Minority Interest
7
11
4
1
1
1
107
122
127
123
129
130
136
133
128
126
10
208
626
866
997
1 599
2 287
Other Liabilities
6
4
2
2
1
0
8
32
63
67
79
107
115
147
113
465
197
884
1 853
1 400
549
317
909
Total Liabilities
177
N/A
101
-43%
48
-52%
112
+133%
348
+211%
245
-30%
537
+119%
696
+30%
1 177
+69%
1 217
+3%
1 618
+33%
1 223
-24%
1 389
+14%
2 777
+100%
3 992
+44%
9 730
+144%
10 497
+8%
12 739
+21%
14 094
+11%
14 074
0%
12 960
-8%
15 458
+19%
16 753
+8%
Equity
Common Stock
54
68
68
80
81
81
81
81
81
81
81
427
427
427
427
421
421
418
456
457
486
486
519
Retained Earnings
30
89
162
226
270
332
495
623
775
954
1 265
1 546
2 300
3 085
3 855
4 913
5 788
6 370
6 280
6 697
7 411
8 825
10 103
Additional Paid In Capital
12
103
103
410
428
428
428
428
428
428
428
2 937
2 937
2 937
2 937
2 765
2 699
1 042
1 716
3 077
4 159
4 250
5 064
Unrealized Security Profit/Loss
0
0
0
5
0
0
0
2
0
0
2
4
2
4
12
6
7
4
2
1
12
1
0
Treasury Stock
0
0
0
0
2
0
0
0
0
0
0
0
0
0
459
306
280
280
280
280
0
0
0
Other Equity
0
13
13
6
6
20
17
8
7
3
7
7
3
25
4
9
289
344
314
226
486
592
386
Total Equity
96
N/A
272
+183%
345
+27%
728
+111%
772
+6%
821
+6%
987
+20%
1 126
+14%
1 277
+13%
1 460
+14%
1 769
+21%
4 908
+177%
5 664
+15%
6 429
+13%
6 768
+5%
7 808
+15%
8 910
+14%
7 891
-11%
8 488
+8%
10 176
+20%
12 531
+23%
14 155
+13%
16 073
+14%
Total Liabilities & Equity
274
N/A
373
+36%
393
+5%
839
+113%
1 120
+33%
1 067
-5%
1 524
+43%
1 822
+20%
2 454
+35%
2 678
+9%
3 387
+26%
6 131
+81%
7 053
+15%
9 206
+31%
10 760
+17%
17 539
+63%
19 408
+11%
20 631
+6%
22 582
+9%
24 250
+7%
25 491
+5%
29 612
+16%
32 825
+11%
Shares Outstanding
Common Shares Outstanding
408
408
408
488
492
493
493
493
493
2 654
2 654
3 321
3 321
3 321
3 275
3 270
3 268
3 229
3 521
3 530
3 762
3 762
3 896
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett